[Translation] A randomized, double-blind, single-dose, 2x2 crossover study to demonstrate the bioequivalence of Tonghua Dongbao Liraglutide Injection and Novozymes in healthy subjects
主要目的:证实通化东宝利拉鲁肽注射液(TD利拉鲁肽注射液)和诺和力®在健康受试者中的药代动力学(PK)生物等效性。 次要目的:评估TD利拉鲁肽注射液和诺和力®在健康受试者中的安全性和耐受性。
[Translation] Main objective: To confirm the pharmacokinetics (PK) bioequivalence of Tonghua Dongbao Liraglutide Injection (TD Liraglutide Injection) and Novoli® in healthy subjects. Secondary objectives: To evaluate the safety and tolerability of TD Liraglutide Injection and Novozyme® in healthy subjects.